Pregled bibliografske jedinice broj: 621229
Minimally invasive laser procedure for early stages of stress urinary incontinence
Minimally invasive laser procedure for early stages of stress urinary incontinence // LAHA, 1 (2012), 67-74 (podatak o recenziji nije dostupan, članak, znanstveni)
CROSBI ID: 621229 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Minimally invasive laser procedure for early stages of stress urinary incontinence
Autori
Fistonić, Ivan ; Findri Guštek, Štefica ; Fistonić, Nikola
Izvornik
LAHA (1855-9913) 1
(2012);
67-74
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Er:YAG laser; stress urinary incontinence (SUI); Smooth mode; nonablative laser treatment; collagen remodeling; collagen synthesis
Sažetak
The objective of this labeled, prospective, single center pilot study study was to assess the efficacy and safety of a novel minimally invasive, nonablative laser treatment in the early stages of SUI. A total of 39 patients suffering from mildtomoderate stress urinary incontinence underwent treatment with an Er:YAG (2940 nm) laser in nonablative fractional mode. Assessment tools included the ICIQUI SF questionnaire for assessing the degree of incontinence and its impact on the quality of life, the Qtip test for evaluating the mobility of the urethra and bladder neck, PISQ12 for assessing quality of life in the area of sexuality, and perineometry for the measurement of muscle strength. Followups were scheduled after 1 month for 39 patients, after 3 months for 22 patients and after 6 months for 6 patients. Preliminary results of posttreatment evaluation showed significant improvement (p< 0.05) in all the domains tested: ICIQUI scores decreased by more than 3 points at all followups. A mean duration of muscle contraction measured with perineometry at 1 month increased by 4.7 s, at 3 months by 11.8 s and at 6 months by 22.8 s. Qtip angle decreased by 14.7˚ at 1 month followup, by 15.9˚ at 3 months and by 22.5˚ at 6 months. PISQ12 scores increased after 1 month by 5.4 points, after 3 months by 5.9 points and after 6 months by 6.6 points. The preliminary results confirm that a minimally invasive, nonablative fractional laser treatment (IncontiLaseTM) is an effective, safe and comfortable treatment option for symptom relief in patients with mild and moderate SUI.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti